Loading
Latest filing published 22 Jun 2026 for AEON Biopharma, Inc.. Read the official filing
No signal scores available.
Marc Forth discloses dealings in AEON Biopharma, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 31 August 2024 to 17 June 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 22 June 2026 came the latest disclosure, a share grant in AEON Biopharma, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations